Information about the clinical trial is posted on clinicaltrials.gov and on the FAST website at www.CureAngelman.org. FAST was recently featured on the NBC special, American Giving Awards, when Golden Globe winning actor Colin Farrell received the Leadership Award for his work with the organization. FAST secured the funding for this clinical trial through the Vivint Gives Back project.
About Angelman Syndrome
Angelman Syndrome is a severe neurological disorder characterized by profound developmental delays, epilepsy, and problems with motor coordination (ataxia) and balance. Individuals with AS do not develop functional speech. The seizure disorder in individuals with Angelman Syndrome can be difficult to treat. Feeding disorders in infancy are common, and some persist throughout childhood. Sleeping difficulties are commonly noted in individuals with Angelman Syndrome. AS affects all races and both genders equally and occurs in approximately one in 10,000 to 15,000 births. For more information about Angelman Syndrome, please visit http://www.CureAngelman.org.
FAST is a Section 501(c)(3) non-profit research organization narrowly focused on funding research that holds the greatest promise of treating Angelman Syndrome. FAST-Trac Grants and Grants-in-Aid are reviewed on a rolling basis with no application deadline. To learn more about FAST's mission and funding priorities, or to make a donation towards FAST's research program visit www.CureAngelman.org.
About USF Health
USF Health's mission is to envision and implement the future of health. It is the partnership of the USF Health Morsani College of Medicine, the College of Nursing, the Coll
|SOURCE Foundation for Angelman Syndrome Therapeutics (FAST)|
Copyright©2010 PR Newswire.
All rights reserved